InnoCan Pharma Corporation INNPF 0.21 InnoCan Pharma Corporation

Home
  /  
Stock List  /  InnoCan Pharma Corporation
Range:0.0908-0.3Vol Avg:509Last Div:0Changes:-0.07
Beta:2.99Cap:0.03BCurrency:USDExchange:PNK
Sector:HealthcareIPO:Fri Nov 27 2020Empoloyees:
CUSIP:CIK:ISIN:CA45783P1027Country:CA
CEO:Ms. Iris BincovichWebsite:https://innocanpharma.com
InnoCan Pharma Corporation, a pharmaceutical company, focuses on the development of various drug delivery platforms combining cannabidiol (CBD) with other pharmaceutical ingredients in the United States, Poland, France, and internationally. The company engages in the research and development of COVID-19 and other condition treatment by using CBD loaded exosomes; and CBD loaded liposomes. Its product includes CBD eye serum, CBD face oil, CBD face cream, CBD facial serum, CBD sleeping mask, CBD recovery lotion, and the Relief & Go spray. The company is also involved in the commercialization and sale of branded CBD integrated pharmaceutical and topical treatment products. InnoCan Pharma Corporation was incorporated in 2018 and is headquartered in Calgary, Canada.

Stock Details

The content provided on this site is for informational purposes only and does not constitute financial, investment, or professional advice. We are not registered investment advisors or financial planners, and we do not provide recommendations or advice on buying, selling, or holding any particular stocks or securities. Any investment decisions should be made based on your own research and consultation with a qualified financial professional. We are not responsible for any financial loss or damages incurred from reliance on the information provided on this site. Please invest responsibly and seek professional advice when needed.
DMCA.com Protection StatusPowered by StackThrow